Precision medicine is a rapidly-evolving field in the management of cancer. The use of novel molecular or genetic signatures in local-regional management is still in its infancy. Precision Radiation Oncology demystifies this state-of-the-art research and technology.

By describing current existing clinical and pathologic features, and focusing on the ability to improve outcomes in cancer using radiation therapy, this book discusses incorporating novel genomic- or biology-based biomarkers in the treatment of patients moving radiation oncology into precision/personalized medicine. Precision Radiation Oncology provides readers with an overview of the new developments of precision medicine in radiation oncology, further advancing the integration of new research findings into individualized radiation therapy and its clinical applications.

Bruce Haffty, M.D. is an international expert in breast radiation oncology. He is a professor and chairman in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School, Rutgers New Jersey Medical School, and Rutgers Cancer Institute of New Jersey. He also serves as Chief of Staff of the Rutgers Cancer Institute.

Sharad Goyal, M.D. is an associate professor and director of clinical and translational research in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute of New Jersey. He is a board-certified radiation oncologist whose clinical practice is primarily focused on breast and brain cancers.